NA
Nordwand Advisors’s NovoCure NVCR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.57M | Hold |
256,628
| – | – | 0.72% | 41 |
|
2025
Q1 | $4.57M | Sell |
256,628
-55,527
| -18% | -$989K | 1.72% | 5 |
|
2024
Q4 | $9.3M | Sell |
312,155
-2,717,669
| -90% | -$81M | 3.83% | 3 |
|
2024
Q3 | $47.4M | Buy |
3,029,824
+1,514,824
| +100% | +$23.7M | 12.67% | 3 |
|
2024
Q2 | $26M | Hold |
1,515,000
| – | – | 11.32% | 3 |
|
2024
Q1 | $23.7M | Hold |
1,515,000
| – | – | 9.2% | 3 |
|
2023
Q4 | $22.6M | Hold |
1,515,000
| – | – | 5.97% | 3 |
|
2023
Q3 | $24.5M | Hold |
1,515,000
| – | – | 4.85% | 3 |
|
2023
Q2 | $62.9M | Hold |
1,515,000
| – | – | 10.78% | 3 |
|
2023
Q1 | $91.1M | Hold |
1,515,000
| – | – | 14.85% | 3 |
|
2022
Q4 | $111M | Buy |
+1,515,000
| New | +$111M | 13.86% | 3 |
|